Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference

View Full Size 

Download

• Full Size JPEG, 600x176, 26.2 KB
• Small JPEG, 480x141, 20.2 KB
• Preview JPEG, 144x42, 5.0 KB
• Thumbnail JPEG, 120x35, 4.4 KB